Pharmaca provides naloxone without prescription in Seattle
Pharmacists at Pharmaca Integrative Pharmacy’s four Seattle-area locations have begun dispensing the opioid overdose antidote naloxone to patients without a prescription.
Pharmacy
CVS kicks off in-store fundraiser for cancer research
CVS Health has launched its fourth annual in-store fundraising campaign to benefit Stand Up To Cancer (SU2C) at CVS Pharmacy stores nationwide. Through Nov. 19, CVS Pharmacy customers can support Stand Up To Cancer by making a $1, $3 or larger donation at checkout or online at StandUpToCancer.
Analyst: Latest Amazon pharmacy fears overblown
Fears among pharmacy players and investors that e-tail giant Amazon plans to enter the industry may be overblown — at least for the time being, according to Jefferies analyst Brian Tanquilut. Pharmacy stocks, including pharmacy retailers and suppliers, have taken a pounding since the St.
PerceptiMed names senior director of manufacturing
Kesavan Srikumar has joined pharmacy automation provider PerceptiMed Inc. as senior director of manufacturing. PerceptiMed noted that Srikumar brings more than 30 years of manufacturing experience to the company. Previously, he held management positions at Solectron, Flextronics and Aviat Networks.
Trump declares opioid abuse a public health emergency
Following through on pledge made this summer, President Donald Trump has formally declared the nation’s growing opioid abuse epidemic as a public health emergency.
Washington faces Rx reimbursement challenge
The National Association of Chain Drug Stores, National Community Pharmacists Association and Washington State Pharmacy Association (WSPA) are challenging changes to Medicaid pharmacy reimbursement in Washington state.
CVS Health deploys drug disposal kiosks in stores
CVS Health has officially expanded its safe medication disposal kiosk program to CVS Pharmacy stores.
CVS Caremark unveils performance-based Rx network
For its CVS Caremark pharmacy benefit manager, CVS Health next year plans to roll out a new 30,000-store pharmacy network anchored by CVS Pharmacy and Walgreens. CVS said late Tuesday that the performance-based network also will include up to 10,000 independent community pharmacies nationwide.
AstraZeneca cleared to market Bydureon BCise
Early next year, AstraZeneca plans to release Bydureon BCise, a new formulation of Bydureon (exenatide extended-release) injectable suspension in an improved once-weekly, single-dose autoinjector for adults with type 2 diabetes.
NACDS tackles opioid crisis in letter to Trump
The National Association of Chain Drug Stores has made four policy proposals to help fight opioid abuse in a letter to President Donald Trump.
Walgreens stocks all pharmacies with Narcan Nasal Spray
Walgreens is now carrying Adapt Pharma’s Narcan, a nasal spray form of opioid overdose antidote naloxone, in all of its more than 8,000 pharmacies nationwide.
McKesson U.S. Pharmaceutical president to depart
McKesson U.S. Pharmaceutical president Mark Walchirk is leaving the company to become president and chief executive officer of Patterson Companies Inc., a distributor serving the dental and animal health markets. Patterson said Tuesday that Walchirk is slated to start at the company on Nov. 20.
Rite Aid gives Medicare Part D guidance to seniors
Rite Aid Corp. has begun offering assistance to seniors during the Medicare Part D open enrollment period. Through Dec.
FDA OKs new indications for Janssen’s Simponi Aria
Janssen Biotech Inc. has gained Food and Drug Administration approval for Simponi Aria (golimumab) to treat adults with active psoriatic arthritis or active ankylosing spondylitis.
Bayer Consumer Health makes pair of appointments
Next week, Brenda Raphael is slated to take the reins as senior vice president and general manager of the therapeutics business unit of Bayer Consumer Health commercial operations for North America.
McKesson CEO agrees opioid crisis is national emergency
McKesson Corp. chairman and chief executive officer John Hammergren has endorsed President Donald Trump’s plan to designate the opioid abuse crisis as a national emergency.